Nightly
Community- Dose
- 100 mcg of each (200 mcg total)
- How often
- Once nightly
- How long
- 8–12 weeks, then about 4 off
Most common. Fasted, about 30 minutes before bed.
CJC-1295 (no DAC) 5 mg + ipamorelin 5 mg
Pairs a GHRH analog with a ghrelin-receptor agonist. They act on different receptors, and this is the most common GH-secretagogue pairing.
CJC-1295 + Ipamorelin isn’t an approved product anywhere. Here is where each part stands.
Sport status follows the WADA 2026 Prohibited List. Each part’s page has its full status, including US compounding. Checked October 5, 2026.
100 mcg of each (200 mcg total) 1–2× daily, most often once at bedtime.
12 weeks on, 4 off, shown over 26 weeks
The ways CJC-1295 + Ipamorelin is most often run, each tagged with where it comes from.
Most common. Fasted, about 30 minutes before bed.
Fasted doses through the day, often including one at bedtime.
Subcutaneous injection, rotating sites; one shot delivers both peptides. Fasted, usually at bedtime.
No published guidance. Skip the missed dose and take the next one on schedule; don’t double up.
A short GH pulse from both peptides; CJC-1295 without DAC has a half-life of about 30 minutes.
CommunityMarketed for sleep, recovery and body composition, but no trial of the blend exists and FDA found no data supporting these uses.
CommunityFlushing, headache or injection-site redness
Usually brief. Rotate sites; stop with hives, swelling or breathing trouble.
Water retention, joint aches or hand tingling
GH-related. Lower the dose or stop if it persists.
Increased hunger
Reported with ipamorelin; usually mild.
Higher blood sugar
GH raises glucose. Check fasting glucose, especially with prediabetes or diabetes.
Hives with face or throat swelling, trouble breathing, chest pain, or numbness that keeps getting worse: stop and get medical help.
Usually run on its own.
| Vial | Water | Common dose | Draw | Each dose contains | Action |
|---|---|---|---|---|---|
| 5 + 5 mg | 2.5 mL | 100 mcg CJC-1295 (no DAC) | 5 units (0.05 mL) | 100 mcg CJC-1295 (no DAC) 100 mcg Ipamorelin |
Syringe units for common doses at different water volumes. Select a cell to open it in the calculator.
| DoseCJC-1295 (no DAC) share | Water added | |||
|---|---|---|---|---|
| 1 mL | 2 mL | 2.5 mL | 3 mL | |
| 50 mcg | ||||
| 60 mcg | ||||
| 75 mcg | ||||
| 100 mcg | ||||
| 150 mcg | ||||
| 200 mcg | ||||
| 250 mcg | ||||
| 300 mcg | ||||
U-100 insulin syringe: 100 units is 1 mL. Draws over 100 units show in mL. Faded values are under 2 units, which is hard to measure. Check that your vial holds the larger volumes.
Powder: frozen or refrigerated. Mixed: 2–8 °C, use within about 4 weeks.
Pairs a GHRH analog with a ghrelin-receptor agonist. They act on different receptors, and this is the most common GH-secretagogue pairing.
No. It is a fixed mix of CJC-1295 (no DAC) and Ipamorelin, and the blend itself hasn’t been approved or studied. The status section above shows where each part stands.
From community reports, not established: 100 mcg of each (200 mcg total) 1–2× daily, most often once at bedtime. These are the amounts sources reference, not recommendations.
There’s no single right amount, because the water only sets the strength. With 2.5 mL of bacteriostatic water in a 5 + 5 mg vial, the strength is 4 mg/mL, so 100 mcg CJC-1295 (no DAC) is 5 units on a U-100 insulin syringe. More water makes small doses easier to measure. The dose chart above shows other volumes.
Powder: frozen or refrigerated. Mixed: 2–8 °C, use within about 4 weeks.
Yes. A blend takes the strictest status of its parts: CJC-1295 (no DAC) is banned and ipamorelin is banned.
Not as a blend. Any human data come from studies of its parts, listed on their own pages.
Doses tagged Community come from public dosing guides and user reports, checked against at least two of them. Those sites aren’t named here because many of them sell peptides or earn commissions on them.